Treatment Algorithm series: Discussion w/ Tim Brown, MD MSCE on GEJ/Gastric Adeno ✅ ESOPEC ✅ Adj Nivo ✅ Biomarkers: MSI, PDL1, HER2, CLDN18.2 Full 🔊: ⭐️ ⭐️ ⭐️ “Oncology Brothers” podcast #gism #OncTwitter CancerNetwork®

@TimothyJBrownMD @CancerNetwrk @utswcancer @UGrewalMD @ShaalanBeg @dawood_findakly @rutikamehtaMD @AnwaarSaeed3 @KoheiShitara @BernabeCarolina @realbowtiedoc Blinded by the outstanding beard game here. Do I need to grow one to get invited back onto @OncBrothers?

@TimothyJBrownMD @CancerNetwrk @utswcancer @UGrewalMD @ShaalanBeg @dawood_findakly @rutikamehtaMD @AnwaarSaeed3 @KoheiShitara @BernabeCarolina @realbowtiedoc Oh no no… beard or no beard, you’ll be our go-to GI RadOnc. We are equal opportunists here (facial hair or not 😆)!!

Togoda is Google on Steroids with AI summaries . 🚀 The only thematic AI search engine.👀 It's 100% private with third party proxy. 🧨 Try it today & experience the difference! 👉Follow us @togoda_com 👈 🚀Help us grow & share this post!🚀

@TimothyJBrownMD @CancerNetwrk @utswcancer @NiuSanford @UGrewalMD @ShaalanBeg @dawood_findakly @rutikamehtaMD @AnwaarSaeed3 @KoheiShitara @BernabeCarolina @realbowtiedoc Awesome discussion!!

@TimothyJBrownMD @CancerNetwrk @utswcancer @NiuSanford @UGrewalMD @ShaalanBeg @dawood_findakly @rutikamehtaMD @AnwaarSaeed3 @KoheiShitara @BernabeCarolina @realbowtiedoc Excellent discussion! Does SANO trial change your approach? It showed that for esophageal cancer (> 70% were adenos) managed with CROSS regimen, in the setting of a CR, surveillance was non inferior to surgery